BillionToOne, Inc.
NASDAQ:BLLNMedical - Diagnostics & Research
+$0.84 today
- Market cap
- $4.37B
- Beta
- 0.90
- P/E (TTM)
- 182.6
- EPS (TTM)
- $0.55
Volume 1.44M
Average 0.59M
BLLN Total Non-current Liabilities
All obligations due after more than one year.
BillionToOne, Inc.NASDAQ: BLLN
Total Non-current Liabilities · Q2 FY2026 · quarter ended Jun 2026
Total non-current liabilities rises 32.4% from a year ago
Total non-current liabilities stood at $137.17M at the end of Q2 FY2026, up 32.4% from a year earlier and down 0.6% from the prior quarter.
Context
- Total non-current liabilities amounted to 18.8% of total assets at the end of Q2 FY2026, down 14.3 pp from a year earlier.
- Total non-current liabilities increased in 1 of the last 2 fiscal years.
What to watch
Whether total non-current liabilities keeps rising in the next quarterly balance sheet after a +32.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 104.59M USD
- Year-over-year change
- -1.3%
- 2-year CAGR
- +5.3%
| Period | Period end | Total Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 104.59M | -1.3% |
| FY2024 | 2024-12-31 | 105.92M | +12.2% |
| FY2023 | 2023-12-31 | 94.4M | — |
Total Non-current Liabilities vs competitors
How BLLN compares with its peers on the latest reported figures
- BLLN's Jun 2026 total non-current liabilities of $137.17M is the 7th highest of the 9 companies compared; the peer median is $211.8M.
- Its year-over-year change of +32.4% is the 4th highest of 9, against a peer median of +28.8%.
- Total non-current liabilities amounts to 18.8% of total assets for BLLN, versus a peer median of 20.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $1.79B | +28.3% | +10.1% | 94.8% | |
| Jun 2026 | $459.77M | +4.5% | -12.6% | 34.0% | |
| Jun 2026 | $282.8M | +124.4% | -2.1% | 10.6% | |
| Jun 2026 | $217.49M | -31.4% | -31.4% | 7.6% | |
| Mar 2026 | $206.1M | +37.3% | +5.2% | 30.6% | |
WGSGeneDx Holdings Corp. | Jun 2026 | $162.64M | +41.0% | +1.3% | 33.8% |
BLLNBillionToOne, Inc. | Jun 2026 | $137.17M | +32.4% | — | 18.8% |
| Jun 2026 | $35.23M | -24.4% | +25.2% | 2.4% | |
| Mar 2026 | $22.08M | +29.4% | -8.0% | 1.9% | |
| Peer median (excluding BLLN) | $211.8M | +28.8% | -0.4% | 20.6% | |
Competitors are the stored peer set for BLLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
BillionToOne, Inc.
NASDAQ:BLLN
Intrinsic Alpha fair value
Locked
Current Price
$91.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.